Natriuretic peptides and salt sensitivity: Endocrine cardiorenal integration in heart failure

Congestive Heart Failure

Volumn 8, Issue 1, 2002, Pages 29-48

  Villarreal, Daniel ^a   Freeman, Ronald H ^a   Reams, Garry P ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; DEOXYCORTICOSTERONE ACETATE; HORMONE PRECURSOR; INDOMETACIN; PROATRIAL NATRIURETIC FACTOR[31-67]; RENIN; UNCLASSIFIED DRUG;

ARTERIOVENOUS FISTULA; BODY FLUID; DOG; HEART FAILURE; HEMODYNAMICS; HOMEOSTASIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE;

EID: 0036232502     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.00721.x     Document Type: Review

References (55)

1. ANF the renin-angiotensin system in the regulation of sodium balance: Longitudinal studies in experimental heart failure
2. Renal effects of atrial natriuretic factor
3. Renal actions of atrial natriuretic peptide: Regulation of collecting duct sodium and water transport
4. Electron microscopy of the atrium of the heart
5. Specific granules in atrial muscle cells
6. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats
7. Atrial natriuretic factor: A hormone produced by the heart
8. Diverse biological actions of atrial natriuretic peptide
9. Genetic decreases in atrial natriuretic peptide and salt sensitive hypertension
10. Mechanisms regulating renin release
11. Elevated levels of atrial natriuretic peptide during aldosterone escape
12. Atrial natriuretic factor plays a significant role in body fluid homeostasis
13. Effects of synthetic atrial natriuretic factor on renal function and renin release
14. Renal mechanisms for suppression of renin secretion by atrial natriuretic factor
15. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase
16. Atrial natriuretic factor
17. Atrial natriuretic factor secretion in dogs with experimental high-output heart failure
18. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure
19. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor
20. Atrial natriuretic peptide elevation in congestive heart failure in the human
21. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal and hemodynamic responses to peptide infusion
22. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure
23. Neurohumoral responses to chronic myocardial infarction in rats
24. Hemodynamic changes and renal plasma flow in early heart failure: Implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin
25. Effects of acute and chronic antagonism of atrial natriuretic peptide on renal and humoral function in a canine model of early ventricular dysfunction
26. Renal and circulatory mechanisms in congestive heart failure
27. Atrial natriuretic peptide in congestive heart failure in the dog: Plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects
28. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure
29. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure
30. Regulation of cardiac preload by atrial natriuretic peptide in congestive heart failure
31. Effects of renal denervation on postprandial sodium excretion in experimental heart failure
32. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
33. Natriuretic peptide system in human heart failure
34. Evidence that atriopeptin is not a physiological regulator of sodium excretion
35. Renal effects of ANF (95-126), a new atrial peptide analogue, in dogs with experimental heart failure
36. Physiology of natriuretic peptides
37. Atrial natriuretic peptide fragments in dogs with experimental heart failure
38. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
39. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
40. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction
41. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
42. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated heart failure
43. The natriuretic peptides in heart failure
44. Natriuretic peptides and the kidney: Current concepts
45. Molecular biology and biochemistry of natriuretic peptide family
46. Processing of atriopeptin prohormone by nonmyocytic atrial cells
47. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone
48. Three peptides from the ANF prohormone NH2-terminus are natriuretic and/or kaliuretic
49. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure
50. Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans
51. Atrial natriuretic peptide (31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells
52. Effects of indomethacin on the renal actions of atrial natriuretic prohormone fragment 31-67 in normal dogs
53. Modulation of renin secretion by atrial natriuretic factor prohormone fragment 31-67
54. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure
55. Comparison of vessel dilator and long acting natriuretic peptide in the treatment of congestive heart failure